Cellid, Co., Ltd. (299660.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.1x

Market Cap

KRW 70.95B

MomentumView details →

1D Return

−1.03%

YTD Return

−15.56%

RSI (14)

59.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.1x

Market Cap

KRW 70.95B

RSI (14)

59.4

MomentumView details →

1D Return

−1.03%

YTD Return

−15.56%

ProfitabilityView details →

Gross Margin

5.11%

Net Margin

−262.80%

EBITDA Margin

−83.22%

ROE (TTM)

−51.02%

ROA (TTM)

−28.28%

Asset Turnover

0.10x

GrowthView details →

Revenue YoY

+49.87%

EPS YoY

−41.73%

FCF YoY

+26.88%

Revenue CAGR 3Y

+164.10%

EPS CAGR 3Y

+41.14%

EBITDA YoY

−51.28%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.63x

Current Ratio

0.57x

Quick Ratio

0.54x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

10.42B

Net Income (TTM)

−27.38B

Op. CF (TTM)

−12.19B

Latest newsMore news →

No recent news for 299660.KQ.

Similar companies

Alibaba Health Information Technology Limited00241.HK BeOne Medicines Ltd.ONC 同仁堂600085.SH 益丰药房603939.SH 康美药业600518.SH 西藏药业600211.SH Find similar companies →

Latest newsMore news →

No recent news for 299660.KQ.